Stockscreener 앱 받기
5.32
0.76%
0.04
시장 영업 전:
6.99
1.67
+31.39%
전일 마감가:
$5.28
열려 있는:
$5.27
하루 거래량:
1.27M
Relative Volume:
0.63
시가총액:
$592.41M
수익:
$433.14M
순이익/손실:
$4.95M
주가수익비율:
149.02
EPS:
0.0357
순현금흐름:
$6.55M
1주 성능:
+13.92%
1개월 성능:
+37.47%
6개월 성능:
+75.00%
1년 성능:
+113.65%
1일 변동 폭
$5.06
$5.40
1주일 범위
$4.645
$5.505
52주 변동 폭
$2.21
$6.71
Organogenesis Holdings Inc Stock (ORGO) Company Profile
명칭
Organogenesis Holdings Inc
전화
781-575-0775
주소
85 DAN ROAD, CANTON, MA
ORGO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
5.32 | 592.41M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
158.06 | 68.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.38 | 47.71B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.63 | 46.12B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.39 | 18.78B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
298.70 | 13.40B | 2.76B | 1.11B | 898.10M | 22.77 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 개시 | Lake Street | Buy |
| 2024-02-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-06-15 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-05-24 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-08-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-01-10 | 개시 | SVB Leerink | Outperform |
| 2019-08-26 | 재개 | Credit Suisse | Outperform |
| 2019-05-02 | 개시 | Credit Suisse | Outperform |
| 2019-04-17 | 개시 | Oppenheimer | Outperform |
| 2019-04-11 | 개시 | SunTrust | Buy |
모두보기
Organogenesis Holdings Inc 주식(ORGO)의 최신 뉴스
Organogenesis Holdings Inc. (NASDAQ:ORGO) Stock Catapults 36% Though Its Price And Business Still Lag The Industry - simplywall.st
ORGO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
How does Organogenesis Holdings Inc (ORGO) change from a tortoise to a hare? - Sete News
Wound Care Biologics Market to Witness Massive Growth by 2032 | - openPR.com
Organogenesis Holdings Inc (NASDAQ: ORGO) Could Slash -20.97% Soon - Stocksregister
Organogenesis Holdings Inc (ORGO) stock on the rise: An overview - uspostnews.com
Recent Insider Activity Could Benefit Organogenesis Holdings Inc (ORGO) - knoxdaily.com
Financial Metrics Unveiled: Organogenesis Holdings Inc (ORGO)’s Key Ratios in the Spotlight - DWinneX
Organogenesis Holdings Inc. (NASDAQ:ORGO) Stake Raised by JPMorgan Chase & Co. - Defense World
Geode Capital Management LLC Sells 7,694 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Market cap of Organogenesis Holdings Inc [ORGO] reaches 574.53M – now what? - dbtnews.com
Riding the Waves: A Guide to Investing in ORGO Stock - investchronicle.com
Organogenesis Holdings Inc (ORGO) is a good investment, but the stock may be overvalued - uspostnews.com
Organogenesis Holdings Inc (ORGO) Stock Behavior Isn’t As Predictable As You Think - Stocksregister
Daily Market Movement: Organogenesis Holdings Inc (ORGO) Sees a 2.85 Increase, Closing at 4.33 - DWinneX
A Detailed Analysis Of Organogenesis Holdings Inc (ORGO) - Marketing Sentinel
Lake Street’s latest rating for ORGO stock - knoxdaily.com
Alliancebernstein L.P. Has $585,000 Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Amniotic Membrane Market Set to Witness Significant Growth - openPR.com
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Acquired by O Shaughnessy Asset Management LLC - Defense World
Wellington Management Group LLP Grows Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Bought by American Century Companies Inc. - Defense World
Organogenesis Supports CMS' Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness - The Manila Times
Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness - TradingView
Medicare Coverage Shift for Wound Care Products Paused: What This Means for Patient Access - Stock Titan
Sei Investments Co. Cuts Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
High Growth Tech Stocks In The US To Watch April 2025 - simplywall.st
Prudential Financial Inc. Has $761,000 Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025 - The Manila Times
Organogenesis Sets Key Q1 Earnings Date: What Investors Should Watch - Stock Titan
Insider-Favored Growth Companies Including Organogenesis Holdings And Two More - simplywall.st
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Organogenesis Holdings Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022ORGO - ACCESS Newswire
Virtu Financial LLC Invests $38,000 in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Charles Schwab Investment Management Inc. Has $2.96 Million Stake in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Highlights Strategic Focus in Investor Presentation - TipRanks
Wound Care Biologics Market Overall Study Report 2025-2032 | - openPR.com
Organogenesis Holdings Inc. (NASDAQ:ORGO) Stock Position Raised by Bank of New York Mellon Corp - Defense World
Bank of New York Mellon Corp Purchases 109,762 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - The AM Reporter
Organogenesis Holdings Inc.(NasdaqCM:ORGO) added to S&P Biotechnology Select Industry Index - MarketScreener
Organogenesis Holdings: Solid Finances Protect From Uncertain Environment (NASDAQ:ORGO) - Seeking Alpha
Organogenesis (NASDAQ:ORGO) Stock Price Down 2.1% – What’s Next? - Defense World
Analyzing Organogenesis (NASDAQ:ORGO) and OnKure Therapeutics (NASDAQ:OKUR) - Defense World
Rhumbline Advisers Acquires 7,621 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Morgan Stanley Increases Organogenesis (NASDAQ:ORGO) Price Target to $6.00 - Defense World
Organogenesis director Michael Driscoll sells $127,535 in stock By Investing.com - Investing.com South Africa
Organogenesis director Michael Driscoll sells $127,535 in stock - Investing.com India
High Growth Stocks Insiders Are Eager To Own - Simply Wall St
Organogenesis (NASDAQ:ORGO) Trading 9.1% Higher on Analyst Upgrade - Defense World
Organogenesis Holdings Reports Strong Q4 Earnings Amid Challenges - TipRanks
Best Growth Stocks To Watch Now – March 1st - Defense World
Organogenesis Holdings Inc (ORGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):